Pharma Focus Asia

Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation Announce New Launch of Mounjaro® 7.5 mg /10 mg /12.5 mg /15 mg Ateos®

Monday, June 12, 2023

Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation announced that “Mounjaro® subcutaneous injection 7.5 mg /10 mg /12.5 mg /15 mg ATEOS®” (Nonproprietary name: Tirzepatide, hereinafter referred called “Mounjaro”), the following sustained release GIP/GLP-1 receptor agonists, was launched in Japan.

Mounjaro® is a unique medication that combines the properties of both GIP (glucose-dependant insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonists. 

Mounjaro® is a medication that is administered once weekly by subcutaneous injection using a single-use autoinjector device called ATEOS. The autoinjector device is equipped with a pre-installed needle, and the injection process is automated.

Mounjaro® is a sustained-release GIP/GLP-1 receptor agonist, and it is available in different strengths: 7.5 mg, 10 mg, 12.5 mg, and 15 mg. This lineup of Mounjaro® provides options for different dosages to suit individual patient needs.

By selectively targeting and activating these receptors, Mounjaro® is designed to improve blood glucose levels. The sustained-release formulation of the medication ensures that its effects last for an extended period, providing a prolonged action to help regulate blood glucose over time.

To administer Mounjaro®, the patient places the autoinjector against their skin and presses the injection button. The needle is automatically inserted under the skin, and a single dose of the filled drug is injected. The patient does not need to set the dose or handle the needle manually, as the device takes care of these steps.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024